Iris L. A. Bodewes

574 total citations
12 papers, 398 citations indexed

About

Iris L. A. Bodewes is a scholar working on Rheumatology, Physiology and Genetics. According to data from OpenAlex, Iris L. A. Bodewes has authored 12 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 8 papers in Physiology and 4 papers in Genetics. Recurrent topics in Iris L. A. Bodewes's work include Systemic Lupus Erythematosus Research (9 papers), Salivary Gland Disorders and Functions (8 papers) and Diabetes and associated disorders (4 papers). Iris L. A. Bodewes is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Salivary Gland Disorders and Functions (8 papers) and Diabetes and associated disorders (4 papers). Iris L. A. Bodewes collaborates with scholars based in Netherlands, France and Sweden. Iris L. A. Bodewes's co-authors include Marjan A. Versnel, Cornelia G van Helden-Meeuwsen, Paul Van Daele, Marie Wahren‐Herlenius, Albin Björk, Xavier Mariette, Eline C. Steenwijk, Jacques‐Eric Gottenberg, Naomi I. Maria and Sylvia Kamphuis and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Iris L. A. Bodewes

12 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris L. A. Bodewes Netherlands 10 224 170 169 77 72 12 398
Sofie L. M. Blokland Netherlands 14 215 1.0× 162 1.0× 83 0.5× 72 0.9× 75 1.0× 26 381
Ildikó Fanny Horváth Hungary 12 160 0.7× 177 1.0× 191 1.1× 39 0.5× 68 0.9× 18 465
Jingxiu Xuan China 9 251 1.1× 76 0.4× 73 0.4× 52 0.7× 42 0.6× 18 354
Lilian Vasaitis Sweden 7 324 1.4× 79 0.5× 155 0.9× 46 0.6× 58 0.8× 9 479
John A. Ice United States 6 131 0.6× 93 0.5× 66 0.4× 42 0.5× 39 0.5× 13 241
Nancy Carteron United States 7 117 0.5× 161 0.9× 91 0.5× 35 0.5× 32 0.4× 10 358
O. Fogel France 8 97 0.4× 74 0.4× 71 0.4× 61 0.8× 44 0.6× 21 267
Rodney Pollard Netherlands 6 268 1.2× 62 0.4× 53 0.3× 54 0.7× 32 0.4× 6 332
Jeanne P. Mitchell United States 9 80 0.4× 311 1.8× 198 1.2× 83 1.1× 30 0.4× 10 507
Juraj Javor Slovakia 11 53 0.2× 105 0.6× 70 0.4× 56 0.7× 30 0.4× 33 311

Countries citing papers authored by Iris L. A. Bodewes

Since Specialization
Citations

This map shows the geographic impact of Iris L. A. Bodewes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris L. A. Bodewes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris L. A. Bodewes more than expected).

Fields of papers citing papers by Iris L. A. Bodewes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris L. A. Bodewes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris L. A. Bodewes. The network helps show where Iris L. A. Bodewes may publish in the future.

Co-authorship network of co-authors of Iris L. A. Bodewes

This figure shows the co-authorship network connecting the top 25 collaborators of Iris L. A. Bodewes. A scholar is included among the top collaborators of Iris L. A. Bodewes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris L. A. Bodewes. Iris L. A. Bodewes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Flessa, Christina‐Maria, Evangelia Zampeli, Maria‐Eleftheria Evangelopoulos, et al.. (2022). Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome. Frontiers in Immunology. 13. 836824–836824. 11 indexed citations
2.
Bodewes, Iris L. A., Cornelia G van Helden-Meeuwsen, Thierry P. P. van den Bosch, et al.. (2022). Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren’s syndrome. Lara D. Veeken. 61(8). 3491–3496. 25 indexed citations
3.
Lendrem, Dennis, James Wason, Jessica Tarn, et al.. (2021). Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatology International. 41(9). 1593–1600. 16 indexed citations
4.
Olsson, Peter, Iris L. A. Bodewes, Anna Nilsson, et al.. (2019). Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren’s syndrome. Rheumatology International. 39(9). 1575–1584. 9 indexed citations
5.
Bodewes, Iris L. A., Peter J. van der Spek, Leticia G. León, et al.. (2019). Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets. Frontiers in Immunology. 10. 312–312. 16 indexed citations
6.
Bodewes, Iris L. A., Jacques‐Eric Gottenberg, Cornelia G van Helden-Meeuwsen, Xavier Mariette, & Marjan A. Versnel. (2019). Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial. Lara D. Veeken. 59(1). 107–111. 51 indexed citations
7.
Groot, Noortje, et al.. (2019). THU0240 GENE EXPRESSION SIGNATURES ARE RELATED TO SPECIFIC SUBSETS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 78. 397–397. 1 indexed citations
8.
Bodewes, Iris L. A., Albin Björk, Marjan A. Versnel, & Marie Wahren‐Herlenius. (2018). Innate immunity and interferons in the pathogenesis of Sjögren’s syndrome. Lara D. Veeken. 60(6). 2561–2573. 52 indexed citations
9.
Bodewes, Iris L. A., Cornelia G van Helden-Meeuwsen, Ruth Huizinga, et al.. (2018). TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis. Journal of Autoimmunity. 91. 97–102. 54 indexed citations
10.
Bodewes, Iris L. A., Naomi I. Maria, Cornelia G van Helden-Meeuwsen, et al.. (2018). Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?. Arthritis Research & Therapy. 20(1). 4–4. 46 indexed citations
11.
Bodewes, Iris L. A., Shereen Al-Ali, Cornelia G van Helden-Meeuwsen, et al.. (2018). Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity. Lara D. Veeken. 57(5). 921–930. 92 indexed citations
12.
Bodewes, Iris L. A. & Marjan A. Versnel. (2018). Interferon activation in primary Sjögren’s syndrome: recent insights and future perspective as novel treatment target. Expert Review of Clinical Immunology. 14(10). 817–829. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026